CMTM3 and neoplasm: Our present study shows that the CpG sites near the core promoter of the CMTM3 gene are nearly devoid of methylation in TGCTs (Figure 5A, 5B), which supports the notion that the aberrant de novo methylation of tumor suppressor genes or tumor-related genes is a rare event in TGCTs [35].